Studies have shown that people who consume higher levels of SFN have lower risk of heart disease. 

This is not surprising, since SFN has been shown to prevent inflammation and to lower ‘bad cholesterol’, which are both considered risk factors for cardiovascular disease.


Bai Y, Wang X, Zhao S, Ma C, Cui J, Zheng Y. Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation. Oxid Med Cell Longev. 2015;2015:407580. doi: 10.1155/2015/407580. Epub 2015 Oct 25. PMID: 26583056; PMCID: PMC4637098.

Zhang X, Shu XO, Xiang YB, Yang G, Li H, Gao J, Cai H, Gao YT, Zheng W. Cruciferous vegetable consumption is associated with a reduced risk of total and cardiovascular disease mortality. Am J Clin Nutr. 2011 Jul;94(1):240-6. doi: 10.3945/ajcn.110.009340. Epub 2011 May 18. PMID: 21593509; PMCID: PMC3127519.

Evans PC. The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease. EPMA J. 2011 Mar;2(1):9-14. doi: 10.1007/s13167-011-0064-3. Epub 2011 Feb 12. PMID: 23199123; PMCID: PMC3405367.

Xin Y, Bai Y, Jiang X, Zhou S, Wang Y, Wintergerst KA, Cui T, Ji H, Tan Y, Cai L. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway. Redox Biol. 2018 May;15:405-417. doi: 10.1016/j.redox.2017.12.016. Epub 2018 Jan 2. PMID: 29353218; PMCID: PMC5975128.